- Home
- RCKY vs KOD Comparison
RCKY vs KOD Comparison
Compare RCKY & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- KOD
- Stock Information
- Founded
- RCKY 1932
- KOD 2009
- Country
- RCKY United States
- KOD United States
- Employees
- RCKY N/A
- KOD N/A
- Industry
- RCKY Shoe Manufacturing
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCKY Consumer Discretionary
- KOD Health Care
- Exchange
- RCKY Nasdaq
- KOD Nasdaq
- Market Cap
- RCKY 196.3M
- KOD 198.4M
- IPO Year
- RCKY 1993
- KOD 2018
- Fundamental
- Price
- RCKY $30.06
- KOD $9.29
- Analyst Decision
- RCKY Buy
- KOD Hold
- Analyst Count
- RCKY 1
- KOD 4
- Target Price
- RCKY $40.00
- KOD $11.75
- AVG Volume (30 Days)
- RCKY 55.3K
- KOD 561.7K
- Earning Date
- RCKY 10-29-2025
- KOD 11-13-2025
- Dividend Yield
- RCKY 2.12%
- KOD N/A
- EPS Growth
- RCKY 24.23
- KOD N/A
- EPS
- RCKY 2.48
- KOD N/A
- Revenue
- RCKY $462,328,000.00
- KOD N/A
- Revenue This Year
- RCKY $7.02
- KOD N/A
- Revenue Next Year
- RCKY $3.96
- KOD N/A
- P/E Ratio
- RCKY $11.78
- KOD N/A
- Revenue Growth
- RCKY N/A
- KOD N/A
- 52 Week Low
- RCKY $11.93
- KOD $1.92
- 52 Week High
- RCKY $33.04
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- RCKY 59.78
- KOD 52.18
- Support Level
- RCKY $28.64
- KOD N/A
- Resistance Level
- RCKY $29.69
- KOD $10.20
- Average True Range (ATR)
- RCKY 0.90
- KOD 0.68
- MACD
- RCKY -0.15
- KOD -0.47
- Stochastic Oscillator
- RCKY 60.73
- KOD 88.51
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.